1-chloro-4-(1-methylcyclohexyl)benzene | 1381982-58-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-chloro-4-(1-methylcyclohexyl)benzene
• CAS: 1381982-58-6
• 化学式: C₁₃H₁₇Cl
• 分子量: 208.731
• InChiKey: QTEUFKYTQDRDOM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.6
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.54
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  0

反应信息

• 作为产物：
  描述：

  5-Cyclohexylidene-2,2-dimethyl-[1,3]dioxane-4,6-dione 、 4-氯苯基溴化镁 以 四氢呋喃 、 乙醚 、 正庚烷 、 二氯甲烷 为溶剂， 反应 2.33h， 生成 1-chloro-4-(1-methylcyclohexyl)benzene
  参考文献：
  名称：

  取代反应中基于碳的离去基团：sp 3-杂交的季铵和叔苄基碳中心的功能化

  摘要：

  描述了路易斯酸促进的取代反应，该反应使用Meldrum酸和5-甲基Meldrum酸作为碳基离去基团，可将未应变的季铵和叔苄基C sp 3 –C sp 3键转变为C sp 3 –X键（X = C，H ，N）。重要的是，就合适的底物和亲核试剂而言，该反应具有广泛的范围，并具有良好至优异的产率（通常＞ 90％）。

  DOI：

  10.1021/ol301442z

文献信息

• CETP INHIBITORS DERIVED FROM BENZOXAZOLE ARYLAMIDES
  申请人：Hunt Julianne A.

  公开号：US20100197630A1

  公开（公告）日：2010-08-05

  Compounds having the structure of Formula I, including pharmaceutically acceptable salts of the compounds, are potent CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. In formula I, A-B is an arylamide moiety.

  具有I式结构的化合物，包括该化合物的药物可接受的盐，是有效的CETP抑制剂，可用于提高高密度脂蛋白胆固醇，降低低密度脂蛋白胆固醇，并用于治疗或预防动脉硬化。在公式I中，A-B是一个芳香酰胺基团。
• COMPOUND CAPABLE OF INHIBITING 11-BETA HYDROXYSTERIOD DEHYDROGENASE
  申请人：Vicker Nigel

  公开号：US20110112151A1

  公开（公告）日：2011-05-12

  There is provided a compound of formula R 1 —CO—X—Y—Z—R 2 wherein X and Z are each optional groups that are, independently, saturated or unsaturated carbon chains having a length of 1 to 3 carbons; Y is SO, S, SO 2 , CH═CH, CH 2 CH 2 or O; R 1 is wherein denotes the point of attachment; R 2 is a heteroaryl group comprising an optionally substituted 5 or 6 membered ring, which ring contains only carbon and at least one nitrogen, or contains only carbon, and at least two nitrogens and at least one sulfur; and wherein (i) when R 1 is and —CO—X—Y—Z— is CO—CH 2 —SO, CO—CH 2 —S, or CO—CH 2 —SO 2 , R 2 is other than and; (ii) when R 1 is and —CO—X—Y—Z— is —CO—CH 2 —O—, R 2 is other than

  提供了一个化合物的公式R1—CO—X—Y—Z—R2，其中X和Z是可选的基团，它们分别是具有1至3个碳原子的饱和或不饱和碳链；Y是SO、S、SO2、CH═CH、CH2CH2或O；R1是其中的连接点；R2是一个杂环基团，包括一个可选取代的5或6元环，该环仅包含碳和至少一个氮，或仅包含碳、至少两个氮和至少一个硫；其中(i)当R1是且—CO—X—Y—Z—为CO—CH2—SO、CO—CH2—S或CO—CH2—SO2时，R2不是和；(ii)当R1是且—CO—X—Y—Z—为—CO—CH2—O—时，R2不是。
• Cycloalkyl inhibitors of potassium channel function
  申请人：Bristol-Myers Squibb Company

  公开号：EP2253328A1

  公开（公告）日：2010-11-24

  Novel cycloalkyl compounds useful as inhibitors of potassium channel function (especially inhibitors of the Kvl subfamily of voltage gated K+ channels, especially inhibitors Kv1.5 which has been linked to the ultra-rapidly activating delayed rectifier K+ current IKur), methods of using such compounds in the prevention and treatment of arrhythmia and IKur-associated conditions, and pharmaceutical compositions containing such compounds.

  可用作钾通道功能抑制剂的新型环烷基化合物（特别是电压门控 K+ 通道 Kvl 亚家族的抑制剂，尤其是与超快速活化延迟整流 K+ 电流 IKur 有关的 Kv1.5 抑制剂）、使用此类化合物预防和治疗心律失常及 IKur 相关疾病的方法，以及含有此类化合物的药物组合物。
• US8436028B2
  申请人：——

  公开号：US8436028B2

  公开（公告）日：2013-05-07
• [EN] COMPOUND<br/>[FR] COMPOSÉ
  申请人：STERIX LTD

  公开号：WO2009106817A2

  公开（公告）日：2009-09-03

  There is provided a compound of formula R1-CO-X-Y-Z-R2 wherein X and Z are each optional groups independently selected from saturated or unsaturated carbon chains having a length of 1 to 3 carbons; Y is SO, S, SO2, CH=CH, CH2CH2 or O; R1 is selected from the following groups (A) wherein - - - denotes the point of attachment; R2 is a heteroaryl group comprising an optionally substituted 5 or 6 membered ring, which ring contains only carbon and at least one nitrogen, or contains only carbon, and at least two nitrogens and at least one sulphur; and wherein (i) when R1 is group (B) and -CO-X-Y-Z- is CO-CH2-SO, CO-CH2-S, or CO-CH2-SO2, R2 is other than group (C) and; (ii) when R1 is group (D) and -CO-X-Y-Z- is -CO-CH2-O-, R2 is other than group (E).